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ESCRT complexes form the main machinery
driving protein sorting from endosomes to lyso-
somes. Currently, the picture regarding assem-
bly of ESCRTs on endosomes is incomplete.
The structure of the conserved heterotrimeric
ESCRT-I core presented here shows a fan-like
arrangement of three helical hairpins, each
corresponding to a different subunit. Vps23/
Tsg101 is the central hairpin sandwiched be-
tween the other subunits, explaining the critical
role of its ‘‘steadiness box’’ in the stability of
ESCRT-I. We show that yeast ESCRT-I links di-
rectly to ESCRT-II, through a tight interaction of
Vps28 (ESCRT-I) with the yeast-specific zinc-
finger insertion within the GLUE domain of
Vps36 (ESCRT-II). The crystal structure of the
GLUE domain missing this insertion reveals it
is a split PH domain, with a noncanonical lipid
binding pocket that binds PtdIns3P. The simul-
taneous and reinforcing interactions of ESCRT-II
GLUE domain with membranes, ESCRT-I, and
ubiquitin are critical for ubiquitinated cargo pro-
gression from early to late endosomes.
INTRODUCTION
The multivesicular body (MVB) protein-sorting pathway
targets transmembrane proteins either for degradation
or for function in the vacuole/lysosomes. The signal for en-
try into this pathway is monoubiquitination of protein
cargo, which results in incorporation of cargo into luminal
vesicles at late endosomes (for reviews see, Katzmann
et al., 2002; Raiborg et al., 2003). Genetic studies in yeasthave identified a group of genes that are crucial for this
process and when mutated result in enlarged endosomes
(Odorizzi et al., 1998; Raymond et al., 1992). A subset of
these genes encodes multisubunit endosomal sorting
complexes required for transport (ESCRTs), which act se-
quentially on endosomal membranes (reviewed in Bowers
and Stevens, 2005; Hurley and Emr, 2006).
Yeast ESCRT-I consists of three protein subunits,
Vps23, Vps28, and Vps37 (Babst et al., 2000; Katzmann
et al., 2001). In humans, ESCRT-I comprises Tsg101,
Vps28, and one of four potential human Vps37 homologs
(Bache et al., 2004; Bishop andWoodman, 2001; Eastman
et al., 2005; Stuchell et al., 2004). ESCRT-I is recruited to
endosomes by an interaction with the Vps27/Hse1p com-
plex (or Hrs/STAM in human), and this recruitment is re-
quired for downstream cargo sorting (Bache et al.,
2003a, 2003b; Bilodeau et al., 2003; Katzmann et al.,
2003; Pornillos et al., 2003). The main role of ESCRT-I is
to recognize ubiquitinated cargo via the UEV domain of
the Vps23/Tsg101 subunit (Bilodeau et al., 2003; Katz-
mann et al., 2001; Martin-Serrano et al., 2003b; Sundquist
et al., 2004; Teo et al., 2004b). A C-terminal ‘‘steadiness
box’’ within Vps23/Tsg101 has been reported to tightly
regulate Tsg101 levels in vivo (Feng et al., 2000). Aberrant
cellular phenotypes are observed if single components of
ESCRT-I are overexpressed or depleted (Doyotte et al.,
2005; Goila-Gaur et al., 2003; Johnson et al., 2005).
There are many parallels between yeast and human
ESCRT-I regarding its core function. However, additional
human Vps37 isoforms may provide extra functionalities
for ESCRT-I. Discovery of new ESCRT-I-interacting part-
ners, such as AIP/ALIX, which binds directly to ESCRT-
III, provides extra branches in the human ESCRT network
not apparent in yeast (Strack et al., 2003; von Schwedler
et al., 2003). Other recently characterized ESCRT-I bind-
ing partners, such as TOM1L1, SIMPLE, and Tal, suggest
additional layers of regulation not yet well understood
(Amit et al., 2004; Puertollano, 2005; Shirk et al., 2005).Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc. 99
Viruses usurp endogenous ESCRT-I to promote their bud-
ding (reviewed in Demirov and Freed, 2004; Morita and
Sundquist, 2004). Partial suppression of an ESCRT-I mu-
tant class E phenotype can be achieved by overexpres-
sion of ESCRT-II, suggesting that ESCRT-I acts upstream
of ESCRT-II (Babst et al., 2002b).
Yeast ESCRT-II is composed of three proteins, Vps22,
Vps25, and Vps36, and the structure of the yeast
ESCRT-II core showed a trilobal arrangement of these
tightly associated subunits (Hierro et al., 2004; Teo et al.,
2004a). Although the biological role of ESCRT-II has
been most thoroughly studied in yeast, it was shown re-
cently that ESCRT-II plays an important role in Drosophila
since mutations in the Vps25 subunit of ESCRT-II activate
Notch and Dpp receptor signaling due to endosomal ac-
cumulation of these receptors (Thompson et al., 2005;
Vaccari and Bilder, 2005). The yeast Vps36 subunit of
ESCRT-II binds ubiquitin using one of its two NZF zinc fin-
gers in its N-terminal region, with an affinity comparable to
the ubiquitin/UEV ESCRT-I interaction (Alam et al., 2004;
Meyer et al., 2002). Surprisingly, the N-terminal region of
the human Vps36, EAP45, also binds ubiquitin despite
having no NZF domain (Slagsvold et al., 2005). ESCRT-II
also directly interacts with ESCRT-III via a Vps25(EAP20)/
Vps20(CHMP6) interaction (Teo et al., 2004a; Yorikawa
et al., 2005).
ESCRT-III consists of four subunits, Vps2, Vps20,
Vps24, and Snf7. ESCRT-III subunits associate with endo-
somal membranes in multiple ways: via the myristoyl
group of Vps20 (Babst et al., 2002a); a Vps20-dependent
interaction with ESCRT-II (Teo et al., 2004a); a direct inter-
action between Snf7 and membranes (Lin et al., 2005);
and binding of Vps24 to PtdIns(3,5)P2 (Whitley et al.,
2003). ESCRT-III recruits accessory proteins such as
Bro1/Alix (Bowers et al., 2004; Katoh et al., 2003; Kim
et al., 2005; Martin-Serrano et al., 2003a; Peck et al.,
2004; von Schwedler et al., 2003), which in turn recruits
the deubiquitinase Doa4 (Luhtala and Odorizzi, 2004). Fi-
nally, the AAA-type ATPase Vps4 disassembles the whole
machinery (Babst et al., 1998; Scott et al., 2005).
The importance of phosphoinositides in the MVB path-
way was first shownwith the discovery that Vps34, a class
III PI-3-kinase producing PtdIns3P, is essential for protein
sorting (Schu et al., 1993). Inhibition of Vps34withwortma-
nin or antibodies causes defects in MVB formation (Fer-
nandez-Borja et al., 1999; Futter et al., 2001). PtdIns3P
is highly enriched in early endosomes and in the luminal
vesicles of MVBs, where it recruits proteins through inter-
actions with several specialized lipid binding domains
(Gillooly et al., 2000).
Three main groups of players in the MVB protein sorting
pathway have been identified: transmembrane ubiqui-
tinated cargo, phospholipids, andmachinery that reversibly
associates with endosomes. To elucidate what drives the
progression of ubiquitinated cargo along this pathway, we
need not only a clear directory of the components involved
but also the architecture of the individual components,
and their interconnections. Here we describe the structure100 Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc.of the conserved ESCRT-I core, which explains numerous
observations previously reported. Furthermore, we pro-
vide evidence that ESCRT-Imakes a stable, direct interac-
tion with ESCRT-II in vitro. This is achieved through the N-
terminal (non-ubiquitin binding) NZF finger, which is part
of the double NZF-finger insertion within theGLUE domain
of Vps36. From the crystal structure, we show that the
GLUE domain is a split PH domain, and we demonstrate
its ability to bind PtdIns3P and translocate to endosomes
in vivo. Importantly, GLUE domain mutations that inhibit
lipid binding also inhibit sorting of ubiquitinated cargo
into the yeast vacuole.
RESULTS
ESCRT-I Core Expression and Crystallization
The three subunits of the S. cerevisiae ESCRT-I complex
were coexpressed in E. coli using a polycistronic expres-
sion vector. Various domain boundaries for each subunit
were tried, guided either by proteolytic products gener-
ated during expression of a full-length complex or se-
quence analysis of conserved domain boundaries. Ex-
pression trials converged on a stable heterotrimeric
complex formed by the C-terminal regions of Vps23 (res-
idues 305–385) and Vps37 (residues 130–213) and the
N-terminal region of Vps28 (residues 1–147) (See Supple-
mental Data). Complexes were purified through an
N-terminal His6 tag on Vps28 and crystallized in space
group P61 (a = 167.9, c = 50.2).
The structure was solved by MAD with a SeMet-
substituted crystal. Although the resolution was low, 3.6 A˚,
this dataset enabled unambiguous assignment of all three
subunits. To assign a reliable sequence register, we intro-
duced 11 sequence landmarks by mutagenesis of endog-
enous hydrophobic residues into methionine and by
soaking crystals with cysteine-reactive heavy metals.
There are two heterotrimers in the asymmetric unit, with
only small differences in the extent of ordered residues
at the C termini of Vps28 subunits and the N termini of
Vps37 subunits.
ESCRT-I Core Structure
The low-resolution structure of the heterotrimeric ESCRT-I
core enabled us to determine the fold and arrangement of
individual subunits and identify a few critical interactions
that maintain this tight heterotrimeric complex. The heter-
otrimeric ESCRT-I core consists of one copy each of
Vps23, Vps28, and Vps37. The structure is primarily com-
posed of three long, parallel helical hairpins, each corre-
sponding to a different subunit (Figure 1A). Each hairpin
forms a rib in a splayed fan, where Vps23 is the middle
rib making direct interactions with the Vps28 subunit on
one side and Vps37 subunit on another. The loops of the
three hairpins converge at the stem of the fan while the
N and C termini of all subunits radiate from the outer rim,
except for the C terminus of Vps28, which has three addi-
tional small helices that fold back and pack against its own
Figure 1. The Crystal Structure of Yeast Heterotrimeric ESCRT-I Core Consists Principally of Three Helical Hairpins
(A) Three orthogonal views of the fan-shaped ESCRT-I core (PyMol).
(B) The conserved sequence motifs involved in intersubunit interactions. Electrostatic interactions are shown schematically (left panel) and on the
ESCRT-I core structure (middle panel, with basic residues shown as blue spheres and acidic residues as red). Additional hydrophobic clusters in-
volved in tight association of these subunits are marked by green spheres (right panel): in the Vps23/Vps28 interface, Phe371Vps23/Ile37Vps28,
Leu40Vps28, Tyr44Vps28, Tyr104Vps28; and in the Vps23/Vps37 interface, Leu345Vps23, Met348Vps23, Ile354Vps23/Leu181Vps37, Phe184Vps37, Ile185Vps37.
(C) Sequence alignment of ESCRT-I yeast (Sc) and human (Hs) subunits. Landmarks that assisted in sequence assignment are shown as red circles
(SeMet) or asterisks (cysteines). The ‘‘steadiness box’’ (brown line) and the 368-RKQF-371 motif (black line) in Tsg101 are marked.
(D) Gel filtration of full-length ESCRT-I, ESCRT-I (D21-Vps37), and ESCRT-I core on a Superdex 200 HR10/30. Apparent size of ESCRT-I (D21-Vps37)
was determined by comparison against either a complete set of gel filtration standards (12.4 to 669 kDa, solid line) or a subset of higher molecular
weight markers (232 to 669 kDa, dashed line). The apparent size of ESCRT-I (D21-Vps37) is 214-280 kDa.
(E) Equilibrium analytical ultracentrifugation of ESCRT-I (D21-Vps37) shows an average apparent size of 105 kDa, well in agreement with an expected
size of a 1:1:1 complex (94.7 kDa).hairpin. No direct interactions between Vps28 and Vps37
are observed in the ESCRT-I core.
The most prominent intersubunit interactions between
the subunits are hydrophobic. Vps23 makes extensivecontacts to both Vps28 (2900 A˚2) and Vps37 (2700 A˚2).
The primary contact region between Vps23 and Vps28 in-
volves helix a2 in Vps23 and helix a1 from Vps28. The ma-
jor contact between Vps23 and Vps37 involves a stretch ofCell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc. 101
helix a1 and a subsequent loop from Vps23 packing
against helix a2 from Vps37. Vps37 has a longer N-termi-
nal helix that points away from the structural core. It corre-
sponds to the most divergent region of the ESCRT-I core
among different species, consistent with it making no
direct interactions with other regions of Vps37 or the
ESCRT-I subunits.
At the heart of the Vps23/Vp28 interface is the 368-
RQQF-371 motif from Vps23, with Arg368Vps23 sand-
wiched between two acidic residues, Glu38 and Glu42
from Vps28. These charged residues are completely con-
served (Figures 1B and 1C). Furthermore, Phe371Vps23 in-
serts into a hydrophobic dimple on Vps28 lined with Ile37,
Leu40, Tyr44, and Tyr104. Mutation of the analogous tet-
rapeptide motif in human Tsg101 (368-RKQF-371) com-
pletely eliminated the interaction with Vps28 and the func-
tion of ESCRT-I in viral budding (Martin-Serrano et al.,
2003b).
The Vps23/Vps37 interface is centered on salt links of
invariant Asp340Vps23 with conserved Arg192Vps37 and
His196Vps37. These basic residues are part of the most
conserved sequence motif in Vps37, 192-R/KxxxHxRR-
199, that maps to the intersection of the Vps23/Vps37
hairpins. An adjacent hydrophobic patch (between
Leu345Vps23/Met348Vps23/Ile354Vps23 and Leu181Vps37/
Phe184Vps37/Ile185Vps37) further anchors this interface to-
ward the stem of ESCRT-I. In addition to contacts within
the ESCRT-I core, Vps37 has further interactions with
the N-terminal region of Vps23/Tsg101, beyond the core
structure (Bache et al., 2004; Eastman et al., 2005; Stu-
chell et al., 2004).
The steadiness box, residues 346–390 in Tsg101, was
shown previously to be important for regulating steady-
state levels of Tsg101 in vivo via a posttranslational mech-
anism (Feng et al., 2000). The steadiness box alone is re-
quired but not sufficient for this activity. This region maps
to half of the Vps23 hairpin, including the a1-a2 loop and
the entire a2 helix. Perhaps the simplest explanation for
the effect of the steadiness box on endogenous Tsg101
levels, is that overexpression of exogenous Tsg101 se-
questers endogenous Tsg101 binding partners (Vps28
and Vps37), resulting in degradation of the free endoge-
nous Tsg101.
ESCRT-I Appears to Be a 1:1:1 Complex that Runs
Anomalously on Gel Filtration
Several previous studies haveestimated the sizeof endog-
enous yeast ESCRT-I as approximately 350 kDa (Babst
et al., 2000; Katzmann et al., 2001). In light of the
ESCRT-I core structure having a 1:1:1 ratio of the three
subunits, we reinvestigated the stoichiometry of the intact
ESCRT-I. When intact ESCRT-I is expressed in E. coli,
a significant proportion of the purified complex has 21 res-
idues clipped from the N terminus of Vps37. Surprisingly,
this hasadramatic effect on theapparentmolecularweight
of the complex by gel filtration. The intact ESCRT-I runs as
an aggregate, which elutes earlier than the 670 kDa thyro-
globulin protein standard. In contrast, the ESCRT-I with102 Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc.this small N-terminal deletion elutes with an apparent mo-
lecular weight of 214–280 kDa (depending on the sets of
standards chosen) (Figure 1D). Given that this N-terminal
region is absent even in fungi other than S. cerevisiae, we
concentrated further analysis on the clipped complex. To
facilitate purification of this complex, Vps37 (D1–21) was
engineered and coexpressed with intact Vps23 and
Vps28, and this complex was used throughout this study
(ESCRT-I (D21-Vps37)).
Unexpectedly, the ESCRT-I complex (D21-Vps37), with
an apparent molecular weight of 214–280 kDa by gel filtra-
tion (Figure 1D), has amuch smaller size by equilibrium an-
alytical ultracentrifugation, with the average apparent mo-
lecular weight of approximately 105 kDa (Figure 1E). A
direct fitting of the data revealed a major component of
85 ± 0.2 kDa (1s) with a minor 170 kDa component. The
expected size for the ESCRT-I (D21-Vps37) with a 1:1:1
stoichiometry is 94.7 kDa. Therefore, it appears that the
ESCRT-I forms a 1:1:1 ternary complex. The long duration
of ultracentrifugation did not affect complex integrity as
judged by gel filtration and SDS gel electrophoresis. The
presence of a minor heavier species could represent
a small fraction of dimeric ESCRT-I.
ESCRT-II Interacts Directly with ESCRT-I
Yeast two-hybrid studies have identified interactions be-
tween ESCRT-I and ESCRT-II (Bowers et al., 2004; von
Schwedler et al., 2003). However, it is currently unclear
whether ESCRT-I and ESCRT-II interact directly or
through an adaptor protein. To test whether these two
complexes can directly interact in vitro, we used analyt-
ical gel filtration and recombinant yeast ESCRT-I and
ESCRT-II, expressed and purified from E. coli. ESCRT-I
and ESCRT-II coelute with an apparent molecular weight
higher than those of individual complexes (Figure 2A), in-
dicating that ESCRT-I and ESCRT-II can form a direct
and stable ‘‘super-complex’’ in vitro. We have also map-
ped the region of ESCRT-I/ESCRT-II interactions to the
C terminus of Vps28 (ESCRT-I subunit, residues 148–
242) and the N terminus of Vps36 (ESCRT-II subunit, res-
idues 1–289). The N-terminal region of human Vps36
(EAP45) was recently named the GLUE domain (GRAM-
like, ubiquitin binding in EAP45) (Slagsvold et al., 2005),
and therefore we will refer to the corresponding 1–289 re-
gion of yeast Vps36 as a GLUE domain. The C terminus of
Vps28 is sufficient for interaction with the Vps36GLUE do-
main as shown by gel filtration (Figure 2B). Furthermore,
when coexpressed in E. coli, the nontagged Vps36
GLUE domain can be copurified with a His6-tagged
Vps28 C terminus (Figure 2C). Preliminary analysis of gel
filtration results suggests a 1:1 stoichiometry. To further
map the region of interaction in Vps36, we compared
the intact GLUE domain (residues 1–289) with an engi-
neered deletion variant from which a yeast-specific inser-
tion encompassing residues 100–251 is removed. In con-
trast to the intact GLUE domain, this deletion variant did
not form a complex with the C terminus of Vps28 (Fig-
ure 2D). We next tested whether the GLUE domain
Figure 2. The Vps28 C Terminus of Yeast
ESCRT-I Interacts Directly with the N-
Terminal NZF Zinc Finger within the
Vps36 GLUE Domain of ESCRT-II
(A) Gel filtration showing a direct interaction be-
tween ESCRT-I (D21-Vps37) and ESCRT-II.
Elution profiles of ESCRT-I (D21-Vps37) alone
(Peak 1), ESCRT-II alone (Peak 2), and amixture
of ESCRT-I (D21-Vps37) with ESCRT-II (Peak
3). Both ESCRT-I and ESCRT-II shift to a higher
molecular weight peak when mixed together,
indicating formation of a super-complex.
SDS-PAGE of samples from each gel filtration
peak are shown in the inset.
(B) Elution profiles of the C-terminal region of
Vps28 alone (Vps28-CT, residues 148–242)
(Peak 4), the GLUE domain of Vps36 alone
(Vps36-NT, residues1–289) (Peak5), andamix-
ture of Vps28-CTwith Vps36-NT (Peak 6). Peak
fractions were analyzed by SDS-PAGE and
stained with Coomassie.
(C) When coexpressed in E. coli, His6-tagged
Vps28-CT and nontagged Vps36-NT can be
copurified by affinity chromatography and gel
filtration.
(D) Elution profile of Vps28-CT and Vps36-NT
(with an internal deletion of residues 100–251)
mixed together did not show a shift to a higher
molecular weight peak, indicating that the in-
sertion is necessary for interaction.
(E) GST-tagged GLUE domain insertion con-
taining both zinc fingers (residues 110–205) is
sufficient to bind Vps28-CT. The isolated
Vps36-NZF-N finger (residues 110–151) binds
directly to Vps28-CT, whereas the isolated
Vps36-NZF-C finger (residues 176–205) does
not.insertion is sufficient for the interaction with the Vps28
C terminus. GST-tagged GLUE domain insertion (residues
110–205) pulls down the His-tagged Vps28 C terminus
(Figure 2E). As the GLUE domain insertion contains two
zinc fingers (NZF-N: residues 110–151 and NZF-C: resi-
dues 176–205), we tested each NZF individually for bind-
ing to Vps28. IsolatedGST-NZF-N binds to the His-tagged
Vps28C terminus, while the isolated GST-NZF-C does not
(Figure 2E). Therefore, the two NZF fingers from Vps36
have different functions: NZF-N binds to ESCRT-I and
NZF-C binds to ubiquitin.
ESCRT-II Preferentially Binds to
PtdIns3P-Containing Lipid Vesicles
Given that ESCRT-II localizes to endosomes in vivo
(Slagsvold et al., 2005), we wanted to investigate whether
it can interact with membranes directly. We previouslyshowed that the ESCRT-II core complex (lacking Vps36
residues 1–370) binds efficiently to Folch lipids in vitro
only in the presence of the ESCRT-III-Vps20 subunit
(Teo et al., 2004a). We have now examined the binding
of full-length ESCRT-II to lipid vesicles.
In contrast to the ESCRT-II core, the full-length ESCRT-II
binds efficiently to lipid vesicles made of Folch lipids
(Figure 3A). No binding to synthetic liposomes made of
PC/PE/PS/cholesterol is observed. Folch lipids constitute
a mixture of phosphoinositides and other lipids isolated
from bovine brains. To define the lipid specificity of
ESCRT-II/membrane interaction, we carried out binding
assays with vesicles having a defined lipid composition
(Figure 3B). Full-length ESCRT-II binds most efficiently
to PtdIns3P-containing lipid vesicles but also significantly
to PtdIns(3,4)P2 and moderately to PtdIns(4)P and
PtdIns(3,5)P2. These results suggest that ESCRT-II hasCell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc. 103
Figure 3. ESCRT-II Binds PtdIns3P via Its
GLUE Domain
(A) Comparison of full-length ESCRT-II and
ESCRT-II core (residues 1–370 deleted, DN-
Vps36) binding to Folch lipids or to control lipo-
somes (PC/PE/PS/cholesterol). P and S indi-
cate ‘‘pellet’’ and ‘‘supernatant’’ fractions after
ultracentrifugation, analyzed by SDS-PAGE
and Commassie staining.
(B) Phosphoinositide specificity of full-length
ESCRT-II using vesicles containing 10%of var-
ious phosphoinositides. The ratios represent
averages of three independent assays. Error
bars represent standard deviations of the aver-
ages.
(C) Isolated Vps36 GLUE domain (residues 1–
289) is sufficient for binding to PtdIns3P-con-
taining liposomes.
(D) Lipid binding by the isolated Vps36 GLUE
domain (residues 1–289) measured from intrin-
sic tryptophanes to the DANSYL probe of the
DANSYL-PS-containing liposomes (PC/PE/
DANSYL-PS/cholesterol/phosphoinositide).
The ‘‘base’’ lipids contain an additional 10%
PC instead of a phosphoinositide.the ability to associate with membranes independently of
ESCRT-I and ESCRT-III.
The GLUE Domain of Vps36 Is Sufficient for
Liposome Binding
Because the ESCRT-II core (lacking N-terminal 1–370 res-
idues of Vps36) shows little tendency to interact with
membranes on its own, we suspected that the PtdIns3P
interaction of the full-length ESCRT-II was due to the
N terminus of Vps36. Indeed, the yeast Vps36 GLUE do-
main binds to PtdIns3P-containing vesicles similarly to
the full-length ESCRT-II complex (Figure 3C). The appar-
ent affinity of the GLUE domain for PtdIns3P-containing
vesicles is approximately 0.1 mM (Figure 3D). Since endo-
somal membranes are highly enriched in PtdIns3P, our re-
sults suggest that the Vps36 GLUE domain may partici-
pate in endosomal localization. The human Vps36 was
shown recently to bind to PtdIns(3,4,5)P3 through its N-
terminal GLUE domain (Slagsvold et al., 2005).
The structural prediction using the Robetta server (Zhou
and Zhou, 2005) suggested that the yeast Vps36 GLUE
domain has a fold that is similar to the PH domain of dy-
namin, with a large insertion encompassing residues 100–
250 between the putative PH domain strands six and
seven (Figure 4A). This insertion contains two NZF zinc fin-
gers and is present in all fungi, but not in metazoa. Sten-
mark and colleagues also predicted a PH domain-like
character of the N terminus of the human Vps36 (Slags-
vold et al., 2005). As the Vps36 PH domain was not recog-
nized in a recently reported genome-wide analysis of104 Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc.yeast PH domains (Yu et al., 2004), almost certainly due
to the large, 150 residue NZF-containing insertion (an in-
sertion as large as the PH domain itself), we wanted to
gain a direct proof that it has a split PH domain fold by
X-ray crystallography. Attempts to crystallise the intact
GLUE domain of Vps36 were not successful. Therefore,
we engineered a construct missing the yeast-specific in-
sertion (encompassing residues 1–99 directly fused to
residues 252–289). The engineered protein crystallized in
space group P21212 (a = 94.5, b = 88.4, and c = 45.9),
with two molecules in the asymmetric unit.
The GLUE Domain of Yeast Vps36 Has
a PH-Domain Fold
The 1.9 A˚ structure was solved by MAD with a SeMet-
substituted crystal. The structure has a typical PH domain
architecture with two curved b sheets and one long a helix
(Figure4C). The twosheets (b1–b4andb5–b7) formabbar-
rel-like structure. The C-terminal a helix is wedged be-
tween the two b sheets, covering a hydrophobic core. Al-
though split PH domains have been proposed previously
(reviewed in Lemmon, 2005), our structure provides the
evidence that the GLUE domain indeed has a split PH-do-
main fold. The site of the insertion is located away from the
putative membrane binding surface and is not occluding
the lipid binding pocket.
The crystal structure reveals a distinct, highly positively
charged pocket occupied by a single sulfate anion (Fig-
ure 4C). The walls of the pocket are built by three loops,
b1/b2, b5/b6, and b7/a1. The sulfate ion is pinned from
Figure 4. Vps36 GLUE Domain Is a Split PH Domain with a Noncanonical Lipid Binding Pocket
(A) Sequence alignment of Vps36 GLUE domains from S. cerevisiae (Sc), S. pombe (Sp), A. thaliana (At), and H. sapiens (Hs). Red spheres indicate
residues that decrease binding to PtdIns3P vesicles whenmutated. Yellow spheres indicate residues within 4 A˚ of the sulfate anion in the lipid binding
pocket. The sequence motif for high-affinity phosphoinositide binding to canonical PH domains is illustrated with the example of DAPP1 below the
alignment.
(B) The GLUE domain mutants were tested for binding to 10% PtdIns3P lipid vesicles by sedimentation assay.
(C) The PH domain of DAPP1 (1FAO) (slate) in complex with Ins(1,3,4,5)P4 (Ferguson et al., 2000) is superimposed on the Vps36 GLUE domain (white).
Ins(1,3,4,5)P4 in the DAPP1 structure occupies a canonical phosphoinositide binding pocket. The sulfate anion in Vps36 GLUE domain resides in
a distinct noncanonical pocket. A cyan sphere marks the position of a large insertion (residues 100–251), which was removed from this construct
(left panel). Surface electrostatic potential of the GLUE domain shows a basic lipid binding pocket marked by the sulfate anion (yellow sticks) (middle
panel). Closeup view of the interactions with the sulfate in the phosphoinositide binding pocket in the Vps36 GLUE domain (right panel) is shown.
Residues within 4 A˚ of the sulfate ion are shown as sticks.
(D) Subcellular distribution of yeast Vps36 GFP-GLUE domain, either wild-type (wt) or R89A mutant, transiently overexpressed in COS-7 cells. Only
wild-type GFP-GLUE domain shows punctate distribution. The endogenous EEA1 (red), an early endosomal marker, partially colocalizes with the
wild-type GFP-GLUE domain, as shown in the merged image (yellow puncta).
(E) The full-length Vps36 with an R89A, R261A double mutation in the lipid binding pocket exhibits a strong defect in GFP-CPS cargo sorting into
vacuoles in the context of vps36D strain. The GFP-CPS hybrid protein is missorted to the limiting membrane (labeled by FM4-64) of the vacuole. Un-
like the vps36D strain, the double mutant does not accumulate prevacuolar endosomes (arrow heads), indicating that MVB sorting is not completely
defective in the double mutant.Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc. 105
two sides by the conserved Arg89 (from b5/b6 loop) and
Arg261 (from b7/a1) (Figure 4C). The charge distribution
and the position of the sulfate ion are consistent with
this pocket being a lipid headgroup binding pocket re-
sponsible for the observed ability of the Vps36 GLUE do-
main to bind PtdIns3P. Modeling of PtdIns3P into this
pocket suggests that Arg89 and Arg261 are putative li-
gands of the 3-phosphate and that Lys38 and Arg86
also form a part of this pocket. Indeed, the R89A and
R261A mutants failed to bind PtdIns3P, while the K38A
and R86A mutants showed reduced lipid binding (Figures
3D and 4B). In contrast, mutations of residues in the region
analogous to the ‘‘canonical’’ PH phosphoinositide bind-
ing pocket, Arg42, Arg44, Tyr56, and Lys61, did not signif-
icantly affect lipid binding (Figure 4B). This Vps36 GLUE
phosphoinositide pocket is clearly different than the
pocket between the b1/b2, b3/b4, and b6/b7 loops used
by the vast majority of characterized PH domains
(Figure 4C) (Ferguson et al., 2000; Lietzke et al., 2000).
The only known exceptions to the canonical phosphoino-
sitide binding pocket are the PH domains of b-spectrin
(Hyvonen et al., 1995) and the Tfb1/p62 subunit of TFIIH
(Di Lello et al., 2005), which bind phosphoinositides in
a pocket on the opposite side of the b1/b2 ‘‘fence,’’ involv-
ing the b5/b6 and b7/a1 loops. Previous analysis of lipid
binding by PH domains (Ferguson et al., 2000) showed
that phosphoinosities are recognized by a characteristic
sequence motif consisting of a Lys in strand b1 followed
by a K/R-x-R motif in strand b2. Superimposing the
structure of the Vps36 GLUE domain on a PH domain
with a ‘‘canonical’’ phosphoinositide binding site, e.g.,
DAPP1, shows that the Vps36 GLUE domain does not
have basic residues equivalent to this motif (Figure 4A).
GLUE Domain of Yeast Vps36 Is Sufficient for
Recruitment to Endosomes
To test the physiological relevance of the observed ability
of the isolated Vps36 GLUE domain to bind to PtdIns3P in
vitro, we examined the cellular distribution of the GFP-
tagged yeast Vps36 GLUE domain (1–289) transfected
into COS-7 cells. While the wild-type GLUE domain has
a punctate distribution throughout the cytosol, the point
mutant in the lipid binding pocket, R89A, which does not
bind to lipids in vitro, shows a diffuse cytosolic staining.
The wild-type GLUE domain partially colocalized with
early endosomal marker EEA1, suggesting that these
puncta are endosomal structures (Figure 4D). Further-
more, we tested a double mutant in the lipid binding
pocket, Vps36R89A,R261A, for its effects on vacuolar sorting
in yeast. This mutant, when expressed in a yeast strain
lacking Vps36 (vps36D) results in strong missorting of
GFP-CPS cargo to the limiting membrane of the vacuole
(Figure 4E). This demonstrates that the lipid binding activ-
ity of the Vps36 GLUE domain plays an important role in
MVB cargo sorting. However, unlike cells lacking Vps36,
the vps36R89A,R261Amutant does not result in the accumu-
lation of endosomal membranes (class E dot), suggesting
thatMVB sorting is not completely disrupted. The stronger106 Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc.phenotype of the vps36Dmutant is probably due to loss of
protein-protein interactions, such as with ESCRT-I and
ESCRT-III, in addition to loss of membrane interactions.
ESCRT-II Binding to ESCRT-I, Ubiquitin, and
Lipid Is Not Competitive
Since theGLUE domain of Vps36 combines three different
binding activities, to phosphoinositides, ESCRT-I, and
ubiquitin, we asked whether these interactions can occur
at the same time or are mutually exclusive. We first exam-
ined whether ESCRT-II can simultaneously interact with
ESCRT-I and liposomes. Purified ESCRT-I alone does
not bind lipid vesicles (Figure 5A). However, ESCRT-I pre-
incubated with the full-length ESCRT-II before addition to
lipid vesicles, cosedimented with ESCRT-II/liposomes
(Figure 5A). Similarly, preincubation with the Vps36 GLUE
domain (Vps36-NT) causes ESCRT-I to cosediment with
lipid vesicles (Figure 5A). ESCRT-I does not cosediment
with either the full-length ESCRT-II or the Vps36GLUE do-
main when the C terminus of Vps28 (ESCRT-I) is deleted
(Figure 5B). These results show that the interaction be-
tween the Vps28 C terminus and the Vps36 GLUE domain
is both necessary and sufficient to recruit ESCRT-I to lipid
vesicles.
In yeast, recognition of ubiquitin by ESCRT-II is medi-
ated by the GLUE domain of Vps36, which contains two
NZF domains, one of which (NZF-C, residues 177–205)
binds ubiquitin (Alam et al., 2004). GST-ubiquitin does
not affect lipid bindingof ESCRT-II, and it efficiently cosed-
iments with ESCRT-II bound to lipid vesicles (Figure 5C).
Similar results were observed with the isolated Vps36
GLUE domain (Figure 5D). An I44A mutation of ubiquitin
that abolishes ubiquitin interaction with many ubiquitin
binding modules (reviewed in Hicke and Dunn, 2003) elim-
inates cosedimentation with ESCRT-II (Figure 5C). Simi-
larly, a mutation in the Vps36 NZF domain (T187G/
F188S) that eliminates ubiquitin binding prevents ubiquitin
from cosedimenting with the Vps36 GLUE/liposomes
(Figure 5D). Finally, we tested whether ESCRT-II can inter-
act with all three binding partners simultaneously. For
theseassays,weusedanESCRT-I complexwith adeletion
of the ubiquitin binding domain of Vps23 (ESCRT-I-DUEV)
to prevent direct binding of ubiquitin to ESCRT-I. When in-
cubated together, all of the partners cosedimented with
vesicles (Figure 5E), suggesting that ESCRT-II is capable
of interacting simultaneously with ESCRT-I (via NZF-N),
ubiquitin (via NZF-C), and lipid vesicles (via PH domain)
in vitro.
DISCUSSION
As a step toward understanding the progression of ubiqui-
tinated membrane cargo from early endosomes to lyso-
somes, we provide insights into the architecture, mem-
brane recruitment, and functional interactions of the
ESCRT machinery driving this process. The conserved
heterotrimeric ESCRT-I core is built from three copies of
a common building block, a long helical hairpin, each
Figure 5. ESCRT-II Can Simultaneously
Interact with ESCRT-I, Ubiquitin, and
Lipid Vesicles via Its Vps36GLUEDomain
(A) ESCRT-I alone or ESCRT-I mixed with
ESCRT-II was incubated with PtdIns3P vesi-
cles and sedimented by ultracentrifugation.
ESCRT-I, on its own, does not sediment with
PtdIns3P vesicles, but it does so in the pres-
ence of ESCRT-II or Vps36 GLUE domain
(Vps36-NT).
(B) ESCRT-I with a deletion of the C-terminal
region of the Vps28 subunit (148–242 deleted,
ESCRT-I(28NT)) does not interact with either
ESCRT-II or the isolated GLUE domain.
(C) ESCRT-II can bind simultaneously to both
ubiquitin (GST-Ub) and PtdIns3P but does not
bind to control vesicles or to the mutant GST-
Ub-I44A.
(D) The Vps36 GLUE domain is sufficient to
cause GST-Ub to sediment with vesicles, and
this is mediated by the NZF-C insertion in
Vps36 because a mutation in NZF-C (T187G/
F188S), shown to be defective in Ub binding
(Alam et al., 2004), prevents GST-Ub from co-
sedimenting. GST-ubiquitin did not sediment
on its own with PtdIns3P-containing vesicles.
The GST-Ub was detected using a Western
blot and an anti-GST antibody.
(E) ESCRT-II can bind simultaneously to
ESCRT-I, ubiquitin, and lipid membranes. Full-
length ESCRT-II was preincubated with GST-
Ub and ESCRT-I (DUEV-EI, residues 1–251 de-
leted from Vps23) before addition to vesicles.
Direct interactions of ESCRT-I (DUEV-EI) and
ubiquitin with ESCRT-II is sufficient for their co-
sedimentation with vesicles. ESCRT-I (DUEV-
EI) and ubiquitin alone do not interact and do
not cosediment with vesicles.corresponding to one of the three subunits. This core is
necessary and sufficient for the assembly of the heterotri-
meric 1:1:1 complex. The additional domains and motifs
extending beyond the core serve as gripping tools for
ESCRT-I critical functions. The ubiquitinated cargo is cap-
tured by the Vps23/Tsg101 UEV domain. The link to the
upstream machinery, Vps27/Hrs, is also provided by the
UEV domain (Pornillos et al., 2003) and, potentially,
through interactions with Vps37 (Eastman et al., 2005).
We show that a link to the downstream machinery is es-
tablished by a direct interaction of a C-terminal domainin Vps28 (ESCRT-I) and the NZF-N domain in the Vps36
subunit (ESCRT-II).
The interaction of ESCRT-I with Vps27/Hrs is required
for efficient recruitment of ESCRT-I to early endosomes
(Bache et al., 2003a; Katzmann et al., 2003). Vps27/Hrs
also could have either a direct or an indirect role in activat-
ing ESCRT-I for its subsequent interaction with ESCRT-II.
Our data now indicate that there could be an additional
mechanism for ESCRT-I membrane recruitment, through
an interaction with the GLUE domain from ESCRT-II,
which itself binds to PtdIns3P. We propose that directCell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc. 107
Figure 6. A Scheme for the Dynamic In-
terplay between Membranes, Ubiqui-
tinated Cargo, and the ESCRTMachinery
Involved in Membrane Protein Sorting to
Lysosomes
Specific binding of Vps27/Hrs to PtdIns3P via
its FYVE domain acts as an initial port of entry
for ESCRT-I to early endosomes and poten-
tially ‘‘primes’’ ESCRT-I for its subsequent in-
teraction with ESCRT-II. Through its GLUE
domain, ESCRT-II pulls ESCRT-I to late endo-
somes. ESCRT-I seems to be in a tug of war
between Vps27/Hrs and the GLUE domain of
ESCRT-II. Similarly, ESCRT-II is pulled by
ESCRT-I on one side and by interactions with
the Vps20 subunit from ESCRT-III on another.
The upstream/downstream contest could be
favored by a branching network to ESCRT-III
since each of the two copies of Vps25 subunit
from ESCRT-II can be pulled by an ESCRT-III.interaction of ESCRT-I with ESCRT-II (itself linked to
downstream ESCRT-III components) could be responsi-
ble for prolonged association of ESCRT-I with maturing
endosomes. Interestingly, human ESCRT-I is found not
only on early endosomes where it colocalizes with Hrs,
but also on late endosomes from which Hrs is largely ab-
sent (Bache et al., 2003a). However, it is not clear whether
this progression to late endosomes is mediated by direct
interaction with Vps36 (which is found on late endosomes
in mammalian cells Slagsvold et al., 2005) or by some
other mechanism. Although themammalian GLUE domain
lacks this NZF insertion, it may have evolved an NZF-inde-
pendent, alternative mechanism to bind ESCRT-I. The ob-
servation that the human Vps36 GLUE domain interacts
with ubiquitin (Slagsvold et al., 2005), despite lacking the
specialized yeast-specific Ub binding NZF finger, illus-
trates that similar surprises may await.
ESCRT-II (through its GLUE domain) binds not only to
PtdIns3P but also significantly to PtdIns4P, PtdIns(3,4)P2,
and PtdIns(3,5)P2. The broader specificity of theGLUEdo-
main for phosphoinositides, when compared to Vps27/
Hrs, which selectively binds to PtdIns3P, could explain
why there is only a partial overlap in endosomal localiza-
tion of these components. In addition, each of the two
Vps25 subunits present in ESCRT-II binds to Vps20, an
ESCRT-III component, and this branching network of in-
teractions could further contribute to broader ESCRT-II lo-
calization (Teo et al., 2004a). In summary, it is tempting to
suggest that Vps27/Hrs and ESCRT-II represent stations
for traffic of ESCRT-I from early to late endosomes.
What remains puzzling is that ESCRT-I and ESCRT-II
readily copurify in vitro yet do not appear to constitutively
associate in cells (Babst et al., 2002a). It would be exciting
if the association of these complexes is regulated in vivo
by other factors, such as modification by phosphoryla-
tion/ubiquitination or by interactions with other proteins
of the endosomal machinery.
Ironically, the Vps36GLUE domain, whichwas not pres-
ent in the previously determined ESCRT-II core structures108 Cell 125, 99–111, April 7, 2006 ª2006 Elsevier Inc.(Hierro et al., 2004; Teo et al., 2004a), turns out to be one of
the busiest domains in ESCRT-II. We solved the crystal
structure of the isolated Vps36 GLUE domain, providing
the evidence that the GLUE domain has a split PH-domain
fold. The GLUE domain acts as a central cog driving the
endosomal ESCRT machinery, through simultaneous in-
teractions with PtdIns3P-containing membranes, ubiqui-
tin, and ESCRT-I. The Vps36 GLUE domain binds
PtdIns3P via a positively charged lipid binding pocket, de-
lineated by the variable loops b1/b2, b5/b6 and b7/a1, in
contrast to the vast majority of characterized PH domains,
which use a different lipid binding pocket. The critical role
of membrane binding by the GLUE domain is apparent
from the strong defect in vacuolar sorting of CPS caused
by mutations in the Vps36 lipid binding pocket. The
emerging picture is that two main functions of the ESCRT
machinery, binding of ubiquitinated transmembrane cargo
and membrane recruitment, can be accomplished by
more than one component of the sorting machinery (Fig-
ure 6). This could enable selective retention, enrichment,
and clustering of ubiquitinated cargo and machinery dur-
ing transition from early to late endosomes, despite the
progressive loss of upstream components, such as
Vps27/Hrs, which play a critical role in the initial ubiquitin
sorting and ESCRT recruiting steps. Similar dynamic fluc-
tuations in other endosomal components, such as Rabs,
occur during early to late endosome progression (Rink
et al., 2005). The multiple, reversible interactions between
ubiquitinated cargo,membranes, andmachinery, together
with branching networks, such as between ESCRT-II and
ESCRT-III, ensure an efficient continuum in protein and
lipid sorting and, ultimately, MVB formation.
EXPERIMENTAL PROCEDURES
Plasmids
The sequences encoding S. cerevisiae Vps23, Vps28, and Vps37
(ESCRT-I) were PCR amplified from genomic DNA (ATCC 9763D)
and cloned into the polycistronic, coexpression vector pOPC,
following the general cloning strategy described by Tan (Tan, 2001).
The resulting construct has aMetAlaHis6 affinity tag preceding residue
Met-1 of Vps28. Vps28 was cloned into the first cassette, Vps23 into
the second, and Vps37 in the third. Mutants were generated using
a QuikChange Mutagenesis Kit (Stratagene). ESCRT-II subunits,
Vps22, Vps25, and Vps36 were cloned as previously described (Teo
et al., 2004a). The N-terminal fragment of Vps36 (residues 1–289)
and a C-terminal fragment of Vps28 (residues 148–242) were cloned
into pOPTH and expressed with an N-terminal MetAlaHis6 tag. Ubiqui-
tin was cloned into the pOPTG vector and expressed with an N-termi-
nal GST tag. All constructs were verified by sequencing.
Protein Expression and Purification
ESCRT-I proteins were coexpressed in C41(DE3) cells, grown at 37ºC
to an OD600nm = 1.0, then induced with 0.3 mM IPTG at 16ºC for 12 hr.
ESCRT-II proteins were grown the sameway but were induced at 37ºC
for 3 hr. Both ESCRT-I and ESCRT-II complexes were purified by Ni2+-
affinity, Q-Sepharose, and gel filtration chromatography. The purified
proteins eluted from gel filtration in 20 mM Tris (pH 7.4), 100 mM
NaCl, and 2 mM DTT. For the isolated Vps36 GLUE domain, the buffer
contained an additional 10 mM (NH4)2SO4.
The GST-fusion proteins for lipid binding assays were purified on
Glutathione Sepharose (Amersham). The resin was washed with buffer
A (50 mM Tris [pH 7.5, 4ºC], and 2 mM DTT) followed by buffer B (50
mM Tris [pH 7.5], 200 mM NaCl and 5 mM b-mercaptoethanol).
GST-fusions were elutedwith buffer C (50mMTris [pH 8.5], 10mMglu-
tathione and 2 mM b-mercaptoethanol), concentrated and desalted
using PD-10 columns (Amersham). Constructs containing NZF zinc fin-
gers were purified in the presence of 10 mM ZnCl2.
ESCRT-I Analytical Gel Filtration and Equilibrium Analytical
Ultracentrifugation
See Supplemental Data.
Crystallization of ESCRT-I Core and Vps36 GLUE Domain
Optimal crystals for the engineered ESCRT-I core were obtained at
17ºC by mixing 20 mg/ml protein with a reservoir solution containing
8%–10% PEG 8000, 8%–9% ethylene glycol, 0.1 M HEPES (pH 7.0–
8.0). Optimal crystals of the yeast Vps36 GLUE domain without the in-
sertion (residues 1–99 directly fused to residues 252–289) were ob-
tained at 17ºC by mixing 6.5 mg/ml protein with a reservoir solution
containing 6% glycerol, 0.1M CHES (pH 9.5), 1M (NH4)2SO4, and
0.2M NaCl. ESCRT-I core and ESCRT-II GLUE domain crystals were
cryoprotected by increasing the concentration of ethylene glycol or
glycerol, respectively, to 25%. Attempts to crystallize the complex of
GLUE domain with soluble head group analogs (diC4-PtdIns3P), either
by cocrystallization or by soaking into preformed crystals, were not
successful, probably due to the presence of high (NH4)2SO4.
Data Collection, Phasing, and Model Refinement
MAD data sets were collected at ESRF beamline ID14-4 using an
ADSC CCD detector. Data collection, phasing, and model refinement
were carried as described in Supplemental Data.
Liposome Binding Assays
For sedimentation assays, synthetic lipid vesicles contained 50% PC
(Avanti, 840053), 20% PE (Avanti, 830022), 10% PS (Avanti, 830032),
10% cholesterol (Sigma, 8667) and 10% of the test phosphoinositide
(Avanti or Echelon). Control vesicles contained an additional 10% PC
instead of the test lipid. Folch lipids were obtained from Sigma (Sigma,
B1502). Phospholipids were dissolved in 1:1 chloroform:methanol
containing 0.1% HCl for 15 min, dried with argon, and dessicated un-
der vacuum for 1 hr. Lipids were rehydrated in a buffer containing 20
mM Tris pH 7.4, 100 mMNaCl, and 1 mM b-mercaptoethanol to a final
concentration of 1 mg/ml followed by sonication. Sedimentation as-
says contained purified proteins (3–15 mM), 0.5 mM MgCl2, and 50 ml
of 1 mg/ml lipid vesicles in 100 ml reactions. After 15 min at 4ºC, reac-tions were sedimented at 140,000  g in a Beckman TLA100 rotor for
15 min at 4ºC. The supernatants (S) and the pellets (P), resuspended in
an equal volume of buffer, were analyzed by SDS-PAGE and stained
with Coomassie. Lipid binding affinities were determined using FRET
as described in Supplemental Data.
Pulldown Assays
Glutathione resin in a binding buffer (PBS with 0.05% Triton X-100,
1 mM ZnCl2, and 5 mM b-mercaptoethanol) was mixed with 250 mg
of GST-tagged protein and 150 mg of His-tagged Vps28-CT and
E. coli cytosol (8 mg/ml). The assay mix was incubated for 1 hr at 4ºC
and washed eight times with PBS/0.05% Triton X-100. Bound proteins
were eluted with SDS sample buffer and analyzed by SDS-PAGE.
Supplemental Data
Supplemental data include one table and supplemental text and can
be found with the article online at http://www.cell.com/cgi/content/
full/125/1/99/DC1/.
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